These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20080206)

  • 1. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
    Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
    Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
    Sparks A; Dayal S; Das J; Robertson P; Menendez S; Saville MK
    Oncogene; 2014 Sep; 33(38):4685-96. PubMed ID: 24121268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetramerization-defects of p53 result in aberrant ubiquitylation and transcriptional activity.
    Lang V; Pallara C; Zabala A; Lobato-Gil S; Lopitz-Otsoa F; Farrás R; Hjerpe R; Torres-Ramos M; Zabaleta L; Blattner C; Hay RT; Barrio R; Carracedo A; Fernandez-Recio J; Rodríguez MS; Aillet F
    Mol Oncol; 2014 Jul; 8(5):1026-42. PubMed ID: 24816189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers.
    Katz C; Low-Calle AM; Choe JH; Laptenko O; Tong D; Joseph-Chowdhury JN; Garofalo F; Zhu Y; Friedler A; Prives C
    Genes Dev; 2018 Mar; 32(5-6):430-447. PubMed ID: 29549180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 mediates nonproteolytic polyubiquitylation of the DEAD-Box RNA helicase DDX24.
    Yamauchi T; Nishiyama M; Moroishi T; Yumimoto K; Nakayama KI
    Mol Cell Biol; 2014 Sep; 34(17):3321-40. PubMed ID: 24980433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
    Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
    Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
    Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT
    Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation.
    Seo SK; Hwang CS; Choe TB; Hong SI; Yi JY; Hwang SG; Lee HG; Oh ST; Lee YH; Park IC
    Oncotarget; 2015 Sep; 6(28):26528-40. PubMed ID: 25605253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis.
    Fraser JA; Worrall EG; Lin Y; Landre V; Pettersson S; Blackburn E; Walkinshaw M; Muller P; Vojtesek B; Ball K; Hupp TR
    J Mol Biol; 2015 Apr; 427(8):1728-47. PubMed ID: 25543083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Localization Signal and p53 Binding Site in MAP/ERK Kinase Kinase 1 (MEKK1).
    Chipps E; Protzman A; Muhi MZ; Ando S; Calvet JP; Islam MR
    J Cell Biochem; 2015 Dec; 116(12):2903-14. PubMed ID: 26018553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells.
    Jin L; Li C; Xu Y; Wang L; Liu J; Wang D; Hong C; Jiang Z; Ma Y; Chen Q; Yu F
    Oncol Rep; 2013 May; 29(5):1983-90. PubMed ID: 23483203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA501-5p induces p53 proteasome degradation through the activation of the mTOR/MDM2 pathway in ADPKD cells.
    de Stephanis L; Mangolini A; Servello M; Harris PC; Dell'Atti L; Pinton P; Aguiari G
    J Cell Physiol; 2018 Sep; 233(9):6911-6924. PubMed ID: 29323708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B-associated transcript 3 (Bat3) stabilizes and activates p53 in a HAUSP-dependent manner.
    Zhang R; Cui D; Xue T; Lang Y; Zhang Y; Li L; Sun H; Kuang Y; Li G; Tang J
    J Mol Cell Biol; 2020 Feb; 12(2):99-112. PubMed ID: 31647545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.
    Zhao K; Yang Y; Zhang G; Wang C; Wang D; Wu M; Mei Y
    EMBO Rep; 2018 Feb; 19(2):305-319. PubMed ID: 29295817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Nef promotes ubiquitination and proteasomal degradation of p53 tumor suppressor protein by using E6AP.
    Ali A; Farooqui SR; Rai J; Singh J; Kumar V; Mishra R; Banerjea AC
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1038-1044. PubMed ID: 32819562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.
    Gao K; Wang C; Jin X; Xiao J; Zhang E; Yang X; Wang D; Huang H; Yu L; Zhang P
    Cancer Lett; 2016 May; 375(1):133-141. PubMed ID: 26926424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XPC promotes MDM2-mediated degradation of the p53 tumor suppressor.
    Krzeszinski JY; Choe V; Shao J; Bao X; Cheng H; Luo S; Huo K; Rao H
    Mol Biol Cell; 2014 Jan; 25(2):213-21. PubMed ID: 24258024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crosstalk between ubiquitin-conjugating enzyme E2Q1 and p53 in colorectal cancer: An in vitro analysis.
    Rasouli M; Khakshournia S; Vakili O; Dastghaib S; Seghatoleslam A; Shafiee SM
    Med Oncol; 2023 Jun; 40(7):199. PubMed ID: 37294480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation.
    Thirusangu P; Vigneshwaran V; Prashanth T; Vijay Avin BR; Malojirao VH; Rakesh H; Khanum SA; Mahmood R; Prabhakar BT
    Angiogenesis; 2017 Feb; 20(1):55-71. PubMed ID: 27743086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2-Driven Ubiquitination Rapidly Removes p53 from Its Cognate Promoters.
    Henningsen KM; Manzini V; Magerhans A; Gerber S; Dobbelstein M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.